Project Grant HT94252510329
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$676K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The Defense Health Agency awarded a $716,069 Project Grant to President And Fellows Of Harvard College, doing business as Harvard Medical School, to conduct research from September 1, 2023 through August 31, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative research and investigate medical solutions for the...
This $539,904 Project Grant was awarded on June 15, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research at the Harvard T.H. Chan School of Public Health to investigate "Genomically Informed Morphological Stromal Signatures to Predict Lethal Prostate Cancer." The research aims to develop innovative methods that leverage genomic and morphological data to improve prediction of aggressive...
This $1,014,000 project grant from the Defense Health Agency will fund research into targeted therapeutic opportunities for ovarian clear cell, small cell, and endometrioid carcinomas at President And Fellows of Harvard College from May 1, 2023 to April 30, 2027. The grant falls under the Military Medical Research and Development program, which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions. Through this...
This federal Project Grant award, valued at $254,233, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports research by Harvard Medical School to investigate the regulation of steroid hormone signaling and lipid metabolism by the tuberous sclerosis complex. The project will run from April 1, 2025 to March 31, 2027. As a sub-recipient, Harvard Medical School has a strong track record of delivering sophisticated...
This $1,186,517 Project Grant was awarded by the Defense Health Agency on August 1, 2023 to Harvard College President & Fellows Of Harvard T.H. Chan School Of Public Health under the Military Medical Research and Development (CFDA 12.420) program. The goal of the 3-year project is to REVEAL AND TARGET LIPIDOMIC VULNERABILITIES TO TREAT METASTATIC MELANOMA. Harvard T.H. Chan School of Public Health will conduct research to investigate new ways to treat this deadly form of skin cancer. No...
The Department of the Army Medical Command awarded a $825,247 Project Grant to President and Fellows of Harvard College through the Military Medical Research and Development program (CFDA 12.420) to support research titled "Improving the Durability of Immunological Memory During Anti-PD-1 Immunotherapy" from September 1, 2022 to August 31, 2025. The grant will fund research at Harvard Medical School in Boston, MA to investigate medical solutions for enhancing long-term immune responses...
This $676,147 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports a research initiative led by Harvard University to develop data-driven biomarker-informed decision analytics to improve the efficacy and reduce the toxicity of immune checkpoint blockade therapy for melanoma patients. The 3-year project aims to leverage advanced analytics and biomarker data to optimize the use of this cutting-edge cancer...
The U.S. Defense Health Agency awarded a $1,134,000 Project Grant to President and Fellows of Harvard College (Harvard University) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "NOVEL BRAIN SHUTTLE-MEDIATED ANTI-TDP-43 THERAPEUTICS FOR AMYOTROPHIC LATERAL SCLEROSIS," supports research to develop novel treatments for amyotrophic lateral sclerosis (ALS) by leveraging brain shuttle technologies. The project will be conducted at Harvard...
This federal Project Grant award, valued at $1,498,368.00 and issued by the Defense Health Agency, supports research conducted by The General Hospital Corporation (doing business as Massachusetts General Hospital) under the Military Medical Research and Development (CFDA 12.420) program. The research aims to elucidate the molecular mechanisms of tumor-immune dynamics and evolution in response to radiation, with the goal of optimizing treatment for high- and very high-risk prostate cancer. The...
The President and Fellows of Harvard College, doing business as Harvard Medical School, was awarded a $4,597,818 project grant from the National Cancer Institute within the Department of Health and Human Services. The grant is funded under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353), which supports cancer research initiatives. Under this award, Harvard Medical School will develop an integrative visualization framework for spatial single-cell cancer datasets...